Gene editing market size | Industry Outlook to 2030

Q: What is the current size of the global gene editing market?

As of 2024, the gene editing market is valued at approximately USD 7.8 billion.

Q: What is the expected market size of gene editing by 2031?

The market is projected to reach around USD 23.5 billion by 2031.

Q: What is the CAGR of the gene editing market between 2024 and 2031?

The market is growing at a CAGR of 17.2% during this period.

Q: What are the key growth factors driving the gene editing industry?

Growth is driven by personalized medicine demand, CRISPR adoption, and R&D investments.

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA4587

Publication Date: Jun 2025

What is the Gene editing Market Size?

According to 6Wresearch internal database and industry insights, the Global Gene editing market was valued at USD 7.8 billion in 2024 and is anticipated to exceed USD 23.5 billion by 2031, registering a steady at a CAGR of 17.2% during the forecast period.

The gene editing market is experiencing significant momentum driven by technological advancements and the increasing prevalence of genetic disorders and chronic disease. The increased focus on personalized medicine, with a significant investment in biotech research, and CRISPR inventions, also to continue to promote growth in the market. In addition, the expanding applications in agriculture and animal biotechnology are contributing to the market growth.

Major Growth Factors of the Gene editing Industry

Rising demand for personalized medicine
Technological advancements in CRISPR and other gene editing tools
Increasing prevalence of genetic disorders
Expanding research and development in genomics
Growing adoption in agriculture and livestock
Government and private sector funding in biotech
Strategic collaborations among biotech firms and academia

Gene editing Market Trends

The gene editing market is witnessing increased adoption of CRISPR-Cas9 technology due to its accuracy and efficiency. A stronger emphasis is being placed on ethical and regulatory compliance, as well as collaborative research design that includes academic, clinical, and commercial participation. In addition, the incorporation of artificial intelligence and bioinformatics can accelerate discovery and therapeutic development.

Emerging Developments in the Gene editing Industry

Recent developments include expanding clinical trials for rare genetic diseases, better delivery methods for in vivo editing, and new tools such as base and prime editing. Increasingly, companies are investigating ex vivo gene therapies and agricultural gene editing to enhance yield and resistance traits. Globally, regulations and agencies are simplifying regulatory frameworks to enable innovation while still ensuring safety.